Grant

Grant RDF

pages:

Phase I Clinical Trial in Humans using Human Fetal Derived Glial Restricted Progenitor Cells ("Q Cells") In Transverse Myelitis
Phase I Study of MEK162 for Children with Progressive or Recurrent Cancer and a Phase II Study of Children with Low-Grade Gliomas and Other Ras/Raf/MAP Pathway Activated Tumors
Phase I Study of MK-1775 with Radiation and Temozolomide In Patients with Newly Diagnosed Glioblastoma and Evaluation of lntratumoral Drug Distribution in Patients with Recurrent Glioblastoma
Phase I Study to Determine the Safety and Tolerability of the Oral Microtubule Destabilizer BAL 101553 in Combination with Standard Radiation in Patients with MGMT Promoter Unmethylated Newly Diagnosed Glioblastoma
Phase I Trial of Sorafenib in Children with Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures
Phase I/II Study of BGB-290 with Temozolomide in Recurrent Gliomas with IDH1/2 Mutations
Phase I/II Study of BNC105P in Combination with Everolimus or Following Everolimus for Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Phase I/II Study of the Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients with Newly Diagnosed Malignant Glioma
Phase I/II Trial of Temozolomide and ABT-888 in Subjects with Newly Diagnosed
Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect
Phase IB Trial of Radium-223 and Niraparib in Patients with Castrate Resistant Prostate Cancer
Phase II Multi-Center, Prospective, Randomized, Double-Blind Study of Nitazoxanide in Acute and Chronic Norovirus in Hematpoietic Stem Cell and Solid Organ Transplant Recipients
Phase II Study of TRC102 in Combination with Temozolomide for Recurrent Glioblastoma
Phase II Trial of Everolimus or Everolimus Plus Paclitaxel as First-line Therapy in Cisplatin-Ineligible Patients with Advanced Urothelial Carcinoma
Phase II Trial of Sildenafil in Newborns with Persistent Pulmonary Hypertension
Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met® XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment
Phase III Development of a New, Energy-Absorbing, Tangent Guardrail End Terminal Under MASH (2011-2012)
Phase O/I Study of AMG 232 Concentrations in Brain Tissue in Patients with Recurrent Glioblastoma and of AMG 232 in Combination with Radiation in Patients with Newly Diagnosed Glioblastoma and Unmethylated MGMT Promoters
Phase-Sensitive X-Ray Breast Tomosynthesis (R09-003)
PHBI Transition
Phenotypic Changes Associated with PH3
Phenotyping AMD: Relating retinal structure and function in early AMD
Phosphatase Activation and Arrhythmias in the Failing Heart
Phosphate and FGF23: Dietary and Molecular Mediators of Health Disparities in Cardiovascular and Kidney Diseases
Phosphate and FGF23: Dietary and Molecular Mediators of Health Disparities in Cardiovascular and Kidney Diseases (Impact of Lowering Phosphate Additive Intake on Mineral Metabolism and Cardiovascular Health in Community-Living Adults)”.
Phosphodiesterase 5: A Novel Target and Inhibitor for Breast Cancer Chemoprevention
Phosphorus-Based Food Additives, Mineral Metabolism and Cardiovascular Health
Photodermatological Effects of Toll Like Receptor-4 (TLR4)
Photodynamic Therapy (PDT) Oncology Registry

pages: